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Abstract: Less than half of older adults with depression achieve remission with antidepressant 
medications,  and  rates  of  remission  are  even  poorer  for  those  with  comorbid  conditions. 
Psychosocial interventions have been effective in treating geriatric depression, either alone 
or  better  yet,  in  combination  with  antidepressant  medications.  Traditional  strategies  for 
nonpharmacological  treatment  of  late-life  depression  do  not  specifically  address  the  co-
occurring  cognitive  impairment  and  disability  that  is  prevalent  in  this  population.  Newer 
therapies  are  recognizing  the  need  to  simultaneously  direct  treatment  efforts  in  late-life 
depression towards the triad of depressive symptoms, cognitive dysfunction, and functional 
disability that is so often found in geriatric depression, and this comprehensive approach holds 
promise for improved treatment outcomes.
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Introduction
Depression is a devastating illness for patients and their families. Although efficacious 
treatments for late-life major depression are available,1,2 depression in older adults is 
underdiagnosed and undertreated,3–5 particularly in primary care settings.6,7 Although 
the treatment of late-life depression with antidepressant medication appears to be 
increasing, disparities exist regarding who receives such treatment.8 When treated with 
pharmacotherapy alone, fewer than half of older adults with major depression achieve 
remission.9–12 Rates of remission are even lower in cognitively impaired,   disabled older 
adults, where these comorbid issues complicate treatment adherence and other elements 
essential to success. As a result, psychosocial interventions are   particularly important 
for the treatment of depressed older adults with comorbid cognitive impairment (CI) and 
disability. This review will address the complex relationship of depression, CI, and dis-
ability and will provide an overview of currently available psychosocial   interventions 
for geriatric depression, with attention to promising therapies that incorporate more 
comprehensive approaches for the most vulnerable depressed, cognitively impaired, 
disabled elders.
The triad of late-life depression, CI, and disability
Maturational changes in the brain may increase vulnerability for the development of 
late-life depression13 and have etiological significance for declines in cognition and 
daily functional skills. Cerebrovascular changes, whether due to aging or disease, can 
compromise the neural connectivity of frontal systems. These alterations, including Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
324
Wilkins et al
connections with the limbic system, have been hypothesized 
to increase vulnerability for depression and contribute to the 
manifestation of executive dysfunction associated with late-
life depression.9,14 Vascular insults need not be large to affect 
these neural systems. Large-scale epidemiological studies 
have found evidence that otherwise asymptomatic white 
matter changes on neuroimaging are associated with mild CI 
in older adults.15–17 Cognitive compromise and disability can 
foster nonadherence and interfere with treatment efforts in 
depressed older adults. Additional evidence suggests that CI 
is associated with poor and slower response to antidepressant 
medications.9,18,19
CI in late-life depression
Cognitive compromise associated with late-life depression 
can present anywhere along a continuum from mild CI to a 
frank dementia. A mood disturbance in an older adult can 
initially present as subjective cognitive complaints. Likewise, 
the existence of depression can exacerbate previously existing 
cognitive difficulties. In community-dwelling residents, the 
combination of impaired cognition and depressive symptoms 
doubles in frequency at 5-year intervals beyond age 70; 
combined depression and cognitive dysfunction are present 
in 25% of individuals aged 85 years or older.20 There is ample 
evidence that the presence of comorbid cognitive deficits is 
associated with reduced treatment responsiveness in late-life 
depression.18,21–24
The relationship of late-life depression and CI is 
complex. Late-life depression often is accompanied by 
executive dysfunction, which manifests as reduced planning, 
initiation, organization, and sequencing.25–27 Cognition can 
be affected in terms of new learning,28 visuospatial skills,29,30 
and reduced psychomotor speed.31 Cognitive deficits may 
persist in depressed older adults even after depression 
remits.32–34 The presence of a dementing disorder in and 
of itself can increase the risk of depression.35 Conversely, 
the presence of depressive symptoms in cognitively intact 
older adults predicts subsequent cognitive decline.36 There 
is evidence that training in speed-of-processing skills is 
associated with less incidence of depression at follow-up,37,38 
improved health-related quality of life,39 and self-rated 
health,40 whereas training in reasoning skills is associated 
with improved ability to perform instrumental activities of 
daily living.41
Research has noted cognitive differences between 
early-onset and late-onset late-life depression. Individuals 
with late-onset depression (ie, first depressive episode 
occurring at 60 years or older) exhibit more impairment 
in overall cognitive deficits and in memory and executive 
dysfunction than those with early-onset depression.33,42,43 
Furthermore, late age of depression onset is associated with 
the development of dementia in nondemented depressed 
older adults.44
Disability in late-life depression
The World Health Organization conceptualizes disabil-
ity as an overarching term that contains three types of 
dysfunction: compromised body function or structure, 
impairment in activity, and cessation in participation.45 In 
most studies, disability or functional impairment is con-
cerned with problems in any one or all three of these areas. 
The relationship of depression and disability is bidirectional 
with empirical evidence suggesting that late-life depression 
promotes disability, and likewise, disability increases the risk 
of depression.46 Depression leaves older adults vulnerable to 
disability regardless of the presence of medical illness.47–50 In 
those who are already medically compromised, depression 
can increase the chances of disability, independent of the 
severity of the medical illness.49 This predisposition toward 
depression is evident in older psychiatric patients,49,51–53 
medical inpatients,54 primary care patients,55 and older 
community-dwelling residents.56 The course of disability 
parallels the course of depression in that disability scores 
improve as a reflection of improvement in depression over 
time.57,58 Studies have not found significant differences 
between early-onset and late-onset depression in terms 
of disability.42,43 Although depression promotes disability, 
clinical intuition and empirical evidence argue that the reverse 
is also true; disability fosters depression.
Depression is projected to be the second leading cause 
of disability worldwide by 2020.59 Disability resulting from 
medical or neurological illnesses is associated with increased 
risk for a first-onset depressive disorder.47,60 In addition 
to factors such as bereavement, sleep disturbances, and 
prior depression, disability is an important risk factor for 
depression in older adults.61 In homebound elders, chronic 
and new-onset functional impairment are associated with 
increased risk for depression.60 Disability in the form of an 
increased risk of falls is associated with depression in later 
life.62,63 Severity of depression, degree of CI, and medical 
burden explain less than 40% of the variance in disability, 
implying that disability is a broader dimension of health 
status than each of these factors alone.51
The relationship of depression and disability becomes 
even more complex in the presence of CI. On the one 
hand, the effect of late-life depression on disability may be Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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independent of concomitant changes in cognitive status.64 
On the other hand, depression may contribute to disability in 
part due to the CI that often accompanies late-life depression. 
CI contributes to disability in late-life depression even after 
controlling for the effects of severity of depression. Deficits 
in executive functioning (eg, planning, organizing, initiating, 
and shifting) are independently associated with impairment 
in instrumental activities of daily living, such as bill paying, 
doing housework, and taking medication in both demented 
and nondemented elders.52,53 Furthermore, cognitive deficits 
have the greatest effect on daily functioning in nursing home 
residents even after controlling for psychiatric symptoms of 
depression, delusions, and behavioral disturbances.65 There 
is also evidence that cognitive deficits, particularly impair-
ments in problem solving and memory, mediate the effect 
of depression on disability.66
Limited efficacy of antidepressant 
medication in depressed, cognitively 
impaired, older adults
Despite evidence that pharmacotherapy is efficacious in the 
acute treatment of late-life depression, this is not the case 
for those older adults with CI.67 Antidepressant medications 
bring to remission fewer than 40% of elderly depressed 
patients who have some degree of CI.9–12 Cognitive deficits, 
in particular measures of executive dysfunction such as 
reduced information processing speed, have been associated 
with slow and/or poor response to antidepressant treatment 
in this population.18,21–24
The effects of the triad on patients  
and caregivers
Depression, CI, and disability contribute to increased 
medical and psychiatric morbidity and mortality.9,68–73 
This triad also contributes to patient suffering, decreased 
quality of life, impairment in social and interpersonal 
functioning, and even leads to early nursing home place-
ment.74–76 Caregivers of these individuals suffer similar 
consequences, such as decreased quality of life, medi-
cal and psychiatric morbidities,76–79 as well as increased 
risk of mortality.80 Similarly, caregivers of nondemented 
cognitively impaired older adults report increased burden 
and psychiatric morbidity.54,77,81–83 Family caregivers of 
depressed older adults without CI experience burden to a 
similar degree as caregivers of dementia patients.84 As a 
result, late-life depression has deleterious consequences 
not only for depressed older adults but also for those who 
provide direct care to these individuals.
Psychosocial interventions  
in late-life depression
Health care policy restructuring is placing greater demands 
on the use of treatment interventions that can be empirically 
supported. Using the criteria for evidence-based treatments 
set forth by the Committee on Science and Practice of 
the Society for Clinical Psychology (Division 12) of the 
American Psychological Association, several psychosocial 
interventions can be defined as evidence-based: behavioral 
therapy (BT), cognitive BT (CBT), cognitive bibliotherapy, 
problem-solving therapy (PST), brief psychodynamic 
therapy, and reminiscence therapy.85 Using more focused 
criteria, Mackin and Arean86 identified CBT (including 
PST), brief psychodynamic therapy, and to some extent 
reminiscence therapy as evidence-based interventions for 
late-life depression.
Although not without limitations, meta-analyses have 
been helpful in drawing conclusions on the current state of 
psychosocial interventions for late-life depression. Cuijpers 
et al87 analyzed 25 randomized studies and found that these 
treatments had a moderate to large mean effect size. This 
meta-analysis reported no significant differences in the 
effects among psychological interventions (ie, CBT, BT, 
reminiscence therapy, interpersonal psychotherapy [IPT], 
PST, and others), no significant difference in effect of anti-
depressant medication vs psychological intervention, and a 
significantly larger effect of combined antidepressant and 
psychological intervention than antidepressant medication 
alone. In another meta-analysis that included nonrandomized 
studies but accounted for quality of study, Pinquart et al88 
reported that CBT and reminiscence therapy had large effects, 
whereas most of the remaining psychosocial interventions 
had moderate effects.
Cognitive behavioral therapy
CBT in its various forms focuses on the interplay between 
thoughts, feelings, and behaviors. CBT emphasizes the 
identification of emotions and monitoring mood in relation 
to thoughts and behaviors. Cognitive aspects of the treatment 
involve identifying maladaptive and negative thinking 
patterns in depressed individuals, evaluating these thoughts in 
terms of their irrationality, and challenging and restructuring 
these thoughts in such a way as to be more adaptive and 
less depressive. Behavioral aspects of the treatment involve 
activating the patient via activity scheduling, evaluating 
patients’ expectations of their ability to accomplish tasks 
and activities successfully and/or to experience enjoyment 
in activities, and using positive reinforcement of desired Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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behaviors.89–91 In the treatment of late-life depression, CBT 
has been significantly effective in reducing symptoms of 
depression when compared with a nontreatment control 
group.92–97 When compared with other active treatments, 
CBT was as good as other psychotherapies at treating 
depression,92,98–100 was superior or equivalent in maintaining 
treatment gains,98,101 and when used in combination with an 
antidepressant medication, was more effective in reducing 
depressive symptoms than either CBT or antidepressant 
treatment alone.102 More recent studies have continued to 
support CBT as an effective treatment.103,104
Problem-solving therapy
Often considered a form of CBT, PST has garnered evidence 
as an effective treatment for late-life depression. PST consists 
of a structured format through which depressed older adults 
learn specific skills to enhance problem-solving abilities 
and, through successful resolution of problems, decrease 
depression. Problem-solving skills training consists of 
identifying and defining a problem, generating alternative 
solutions, analyzing positive and negative consequences 
of solutions, and carrying out a solution and subsequently 
evaluating the outcome.105 In depressed older adults, PST 
was superior to reminiscence therapy and a wait-list control 
group106 and was more effective than supportive therapy.35,107 
Studies comparing PST with treatment as usual in primary 
care108 and home care109,110 continue to support the usefulness 
of PST for depression in older adults.
Reminiscence therapy
Reminiscence therapy is a long-standing treatment modality 
that has been used to address depression in older adults. 
Based on Erikson’s psychosocial developmental theory 
reminiscence therapy emphasizes the review of life and iden-
tification of meaning and purpose in one’s life. This is done 
through a process of inspection of one’s life through memo-
ries, focusing on both positive and negative experiences, 
and developing perspective. Reminiscence therapy, with its 
emphasis on personal experiences and history, lends itself to 
the older adult context. Studies have found that reminiscence 
therapy has been more effective than nonpsychotherapy social 
services111 and nontreatment conditions.106,112–115 However, its 
effectiveness compared to other active interventions remains 
questionable.116,117
Brief psychodynamic therapy
Psychodynamic therapy, particularly in its brief form, 
has empirical findings that support its effectiveness in 
treating late-life depression. Brief psychodynamic therapy 
focuses on the identification of conflicts and unconscious 
processes, often originating from early developmental 
stages. Brief psychodynamic therapy encourages the devel-
opment of insight and gives importance to the relationship 
and interactions of the therapist and client. As with other 
psychotherapies, more research is required to determine 
brief psychodynamic therapy’s robustness as a treatment 
(eg, in comparison to or combination with antidepressant 
medication).
Interpersonal psychotherapy
Another intervention often cited in the late-life depression 
literature is IPT. IPT focuses on interpersonal problems 
in four areas: role transitions, interpersonal role conflicts, 
grief, and interpersonal skills deficits.118 IPT appears to have 
clinical utility in treating late-life depression119 and potential 
in combination with antidepressant medication.120 More 
recent analyses have indicated that maintenance IPT is not 
as effective as supportive clinical management in sustaining 
gains made in health-related quality of life,121 but it may 
lower the risk of recurrence of major depression in older 
adults who have lower cognitive functioning.122 Although it 
remains a promising treatment for depression in later life, 
IPT continues to lack the empirical requisites for addition to 
the evidence-based intervention listing.86,123
Need for tailored 
nonpharmacological interventions 
for late-life depression
Most psychosocial interventions for the acute treatment of 
geriatric major depression focus on “young–old” (average age 
of 65–70 years), cognitively intact, ambulatory older adults 
who can follow outpatient treatment.86 Clearly, this is only a 
subsample of the population who are in need. Homebound, 
rural, and low-income older adults may not have the same 
access to effective interventions for depression as those 
living in situations more conducive to receiving traditional 
psychotherapeutic treatment.86 Furthermore, interventions 
may not be available or appropriate for ethnically and 
culturally diverse populations. Factors such as comorbid 
illness can also serve as a barrier for treatment. Evidence 
suggests that depressed older adults with comorbid physical 
illness and CI experience reduced intervention effectiveness,88 
which argues for a strong need for new evidence-based 
psychosocial interventions to help depressed older adults 
with CI and disability. Studies have not indicated significant 
treatment remission differences between early-onset and Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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late-onset depression,124 although older adults who had an 
early-onset depression may be slower to remit.125
Targeting the triad
A small number of studies have started to address the triad of 
late-life depression, CI, and disability. These are adaptations 
of the traditional forms of psychosocial therapies for late-life 
depression that accommodate CI and disability, both by what 
is targeted in treatment and by how treatment is executed. 
Another important adaptation is the inclusion of family 
members and caregivers in the treatment.
Psychosocial interventions for depressed 
older adults with mild cognitive deficits
Two interventions have been successfully adapted for 
depression in older adults with mild CI: PST35,107 and 
IPT.126 PST was adapted for depressed older adults with 
mild executive dysfunction, and recent data suggest that 
it is efficacious in reducing depression and disability in 
this population.35,107 IPT was modified for depressed older 
adults with mild CI (IPT-CI) by including the systematic 
incorporation of concerned caregivers into the treatment 
process, with joint patient–caregiver sessions to promote 
better understanding, communication, and respect.126,127 In 
addition, IPT-CI helps both the older adult and his or her 
caregiver through their role transitions that result from cogni-
tive deficits and functional limitations.
Psychosocial interventions for depressed, 
disabled older adults with moderate  
to severe cognitive dysfunction
In patients with more moderate to severe cognitive 
compromise, there can be a spectrum of neuropsychiatric 
features. These include depressive symptoms and other 
behavioral impairments that can be addressed by psychosocial 
interventions. The following psychosocial interventions have 
been proposed for the treatment of major depression in 
advanced CI, including dementia.
CBT for early stage dementia
CBT has been adapted for depressed older adults with mild 
stages of dementia, but no efficacy data are available.128 The 
CBT-mild dementia protocol is 16–20 sessions long and 
includes a comprehensive neuropsychological battery to 
assess the cognitive deficits and the cognitive strengths of the 
patient. The treatment consists of behavioral activation and 
the incorporation of memory aids (eg, notepads and audio 
taping of sessions), as well as the cognitive components 
of examination of the evidence for and against a specific 
condition, listing the pros and cons of situations, and 
experimenting with new attitudes and cognitions in stressful 
situations.128
Problem adaptation therapy
Problem adaptation therapy (PATH) is a relatively new 
12-week home-delivered intervention specifically developed 
to treat late-life major depression presenting with significant 
CI (including mild to moderate dementia) and disability.129,130 
PATH focuses on the patients’ ecosystem, which involves 
the patient, the caregiver, and the home environment. PATH 
utilizes PST as its basic framework to promote adaptive 
functioning and integrates environmental adaptation tools 
(PATH tools), including calendars, checklists, notepads, 
signs, and timers, to bypass the functional and behavioral 
limitations of these patients. Finally, willing and available 
caregivers participate in treatment when the patient cannot 
utilize problem-solving skills, employ environmental adapta-
tions tools, and engage in pleasurable activities. Preliminary 
efficacy data suggest that PATH is effective compared with 
a control condition of home-delivered supportive therapy in 
reducing both depression and disability.129
Behavioral treatment for depression  
in moderate to severe dementia
A behavioral treatment developed by Teri et al131 focused on 
teaching caregivers strategies aimed at increasing patients’ 
pleasant events or aiding them with problem-solving skills. 
In a controlled clinical trial, this behavioral intervention was 
useful in reducing depressive symptoms in older adults with 
major or minor depression and moderate to severe dementia, 
with symptom reduction maintained at 6-month follow-up. 
Another finding of this study was that caregivers of those 
receiving behavioral interventions experienced significant 
reduction in depression compared with those in the con-
trol groups. This behavioral approach is the recommended 
intervention for older adults with depression who are in the 
more moderate to severe stages of dementia.
Conclusion
Clinicians should be aware of the complexities of geriatric 
depression and how problems with cognitive and physical 
functioning play a role in the presentation of depressive 
symptoms. Effective interventions for geriatric depression 
should recognize the older adult’s potential limitations in 
key areas of cognitive functioning, such as information 
processing, organization, and memory, that may impact Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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engagement in therapy and following through of treatment 
plans. Consideration of the individuals’ mobility and 
their ability to independently manage health behaviors 
and routines is essential to the success of the interven-
tion. Treating depressive symptoms in isolation of the 
patients’ cognitive and physical limitations risks slower or 
less-effective reduction in depressive symptoms; however, 
targeting the triad of depression, CI, and disability provides 
a concerted effort to help patients adapt and cope up with 
their problems, promoting successful outcomes for depres-
sion treatment. Although evidence for such multi-faceted 
approaches to treatment is nascent, large-scale studies and 
further intervention development are currently underway. 
Given the high prevalence of depression in older adults, 
establishing more effective treatments is vital to improving 
geriatric mental health and quality of life for patients and 
their families.
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